These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 4920180)

  • 41. Effects of thyroglobulin on thyroid function.
    Burke G; Szabo M
    J Clin Endocrinol Metab; 1972 Oct; 35(4):552-60. PubMed ID: 4340789
    [No Abstract]   [Full Text] [Related]  

  • 42. [Long-acting thyroid stimulator].
    Titov VN
    Klin Med (Mosk); 1969 Oct; 47(10):31-9. PubMed ID: 4915396
    [No Abstract]   [Full Text] [Related]  

  • 43. The nucleic acid content of lymphocytes in thyrotoxicosis.
    Smith JF; Glen AC; Greig WR
    Clin Exp Immunol; 1971 Jun; 8(6):911-6. PubMed ID: 5104635
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Studies on the antigen reacting with the thyroid-stimulating immunoglobulin (LATS) in thyrotoxicosis.
    Benhamou-Glynn N; el-Kabir DJ; Roitt IM; Doniach D
    Immunology; 1969 Feb; 16(2):187-204. PubMed ID: 4181510
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thyroid-stimulating activity in the serum of rabbits immunized with thyroid microsomes.
    Beall GN; Solomon DH
    J Clin Endocrinol Metab; 1968 Apr; 28(4):503-10. PubMed ID: 4868496
    [No Abstract]   [Full Text] [Related]  

  • 46. [Determination of anti-thyroid antibody].
    Shishiba Y
    Nihon Rinsho; 1979 Jun; Suppl():1511-4. PubMed ID: 226738
    [No Abstract]   [Full Text] [Related]  

  • 47. Inhibition of long-acting thyroid stimulator by thyroid particulate fractions.
    Beall GN; Solomon DH
    J Clin Invest; 1966 Apr; 45(4):552-61. PubMed ID: 5937026
    [No Abstract]   [Full Text] [Related]  

  • 48. Thyroid responsiveness in Gravesian ophthalmopathy.
    Mendelsohn LV; Mouton DE; Goldzieher JW
    Arch Intern Med; 1972 Jul; 130(1):119-20. PubMed ID: 5067864
    [No Abstract]   [Full Text] [Related]  

  • 49. Stimulation of the human thyroid by infusions of plasma containing LATS protector.
    Adams DD; Fastier FN; Howie JB; Kennedy TH; Kilpatrick JA; Stewart RD
    J Clin Endocrinol Metab; 1974 Nov; 39(5):826-32. PubMed ID: 4425101
    [No Abstract]   [Full Text] [Related]  

  • 50. [Progress in the studies on the pathogenesis, physiopathology and clinical course of subacute thyroiditis].
    Górowski T; Pliszka A
    Pol Tyg Lek; 1979 Nov; 34(48):1889-91. PubMed ID: 119217
    [No Abstract]   [Full Text] [Related]  

  • 51. Effects of various iodination procedures on the biological activity of LATS.
    Fenzi GF; Romaldini JH; Grasso L; Raccis E; Pinchera A; Baschieri L
    J Nucl Biol Med; 1972; 16(2):55-7. PubMed ID: 4662340
    [No Abstract]   [Full Text] [Related]  

  • 52. Development of a cytochemical section-assay for thyroid stimulators [proceedings].
    Gilbert DM; Besser GM
    J Endocrinol; 1977 Dec; 75(3):40P. PubMed ID: 591846
    [No Abstract]   [Full Text] [Related]  

  • 53. Direct evidence for human thyroidal stimulation by LATS-protector.
    Shishiba Y; Shimizu T; Yoshimura S; Shizume K
    J Clin Endocrinol Metab; 1973 Mar; 36(3):517-21. PubMed ID: 4739312
    [No Abstract]   [Full Text] [Related]  

  • 54. [The determination of long-acting thyroid stimulator (LATS) in thyroid diseases].
    Depisch D; Höfer R; Schatz H
    Wien Z Inn Med; 1968; 49(4):121-30. PubMed ID: 5757238
    [No Abstract]   [Full Text] [Related]  

  • 55. Experimental production of long-acting stimulator in vivo.
    Burke G
    J Lab Clin Med; 1968 Jul; 72(1):17-27. PubMed ID: 4968981
    [No Abstract]   [Full Text] [Related]  

  • 56. Interaction of purified long-acting thyroid stimulator (LATS) and thyroid microsomes in vitro.
    Wong ET; Litman GW
    J Clin Endocrinol Metab; 1969 Jan; 29(1):72-8. PubMed ID: 5762323
    [No Abstract]   [Full Text] [Related]  

  • 57. Dysthyroid exophthalmos.
    Fells P
    Br J Radiol; 1972 Nov; 45(539):870. PubMed ID: 4678363
    [No Abstract]   [Full Text] [Related]  

  • 58. Thyroid eye disease and its relationship to the long-acting thyroid stimulator.
    Hollows FC; Beaumont P
    Trans Aust Coll Ophthalmol; 1969; 1():37-44. PubMed ID: 4250318
    [No Abstract]   [Full Text] [Related]  

  • 59. The lipolytic activity of long-acting thyroid stimulator.
    Kendall-Taylor P; Munro DS
    Biochim Biophys Acta; 1971 Mar; 231(2):314-9. PubMed ID: 5554904
    [No Abstract]   [Full Text] [Related]  

  • 60. Recurrent thyrotoxicosis after subtotal thyroidectomy.
    Hedley AJ; Ross IP; Beck JS; Donald D; Albert-Recht F; Michie W; Crooks J
    Br Med J; 1971 Oct; 4(5782):258-61. PubMed ID: 5171384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.